Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: It is TPL who has been a bit misleading.
I agree that the "584" is a up hill fight. Arm also wrote "Outside of the litigation, TPL continues to assert US Patent 5,440,749 against ARM technology. ARM believes that this patent is not infringed by any ARM technology and that it is also invalid." They did not talk about the Markman ruling on the 336 and 148.
Share
New Message
Please login to post a reply